Patent Infringers Will Walk Free In Turkey, Drug Makers Association Warns
This article was originally published in PharmAsia News
Executive Summary
Unless Turkish law makers act swiftly to enact two amendments to the country's intellectual property rights protection legislation, a regulatory gap will imperil Turkish IP protection and violators of the patent law will walk free, warns the Association of Research-Based Pharmaceutical Companies, an umbrella trade organization for innovative drug makers in Turkey
You may also be interested in...
More Than 200 New Drugs Developed By International Players Encounter Approval Delays in Turkey
A major grouping of pharmaceutical makers in Turkey said that a new government rule requiring separate good manufacturing practice certification from the Ministry of Health has delayed approval for 287 new drugs manufactured by international firms
More Than 200 New Drugs Developed By International Players Encounter Approval Delays in Turkey
A major grouping of pharmaceutical makers in Turkey said that a new government rule requiring separate good manufacturing practice certification from the Ministry of Health has delayed approval for 287 new drugs manufactured by international firms
Turkey's Changing Pharma Market Scene: What Opportunities For MNC Drug Makers?
Situated in one of the globe's most active emerging markets, the Turkish pharmaceutical industry is undergoing fast changes, which could make or break major drug makers, according to Istanbul-based international consulting firm Egon Zehnder International